3O64 image
Deposition Date 2010-07-28
Release Date 2011-04-20
Last Version Date 2024-11-06
Entry Detail
PDB ID:
3O64
Title:
Crystal structure of catalytic domain of TACE with 2-(2-Aminothiazol-4-yl)pyrrolidine-Based Tartrate Diamides
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.88 Å
R-Value Free:
0.21
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:TACE
Gene (Uniprot):ADAM17
Mutations:S266A, V353G, N452Q
Chain IDs:A, B
Chain Length:270
Number of Molecules:2
Biological Source:Homo sapiens
Peptide-like Molecules
PRD_000919
Primary Citation
2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.
Bioorg.Med.Chem.Lett. 21 3172 3176 (2011)
PMID: 21458257 DOI: 10.1016/j.bmcl.2011.01.002

Abstact

TNF-α converting enzyme (TACE) inhibitors are promising agents to treat inflammatory disorders and cancer. We have investigated novel tartrate diamide TACE inhibitors where the tartrate core binds to zinc in a unique tridentate fashion. Incorporating (R)-2-(2-N-alkylaminothiazol-4-yl)pyrrolidines into the left hand side amide of the tartrate scaffold led to the discovery of potent and selective TACE inhibitors, some of which exhibited good rat oral bioavailability.

Legend

Protein

Chemical

Disease

Primary Citation of related structures